Clinical Trial Update: Avelumab With Axitinib in Persistent or Recurrent Cervical Cancer After Platinum-based Chemotherapy [NA]

View source ↗

Summary

A clinical trial evaluating the combination of avelumab and axitinib for persistent or recurrent cervical cancer after platinum-based chemotherapy has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Avelumab (avelumab)
• Axitinib (Axitinib)

Snippet

Sponsor: The University of Hong Kong | Conditions: Cervical Cancer | NA | Status: COMPLETED